Medicare Enrolled
Dr. Thuy Le, M.D.
Hematology & Oncology · Plano, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Le from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Le?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Le
Dr. Thuy Le is a hematology & oncology specialist in Plano, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Le performed 85,813 Medicare services across 2,885 unique beneficiaries.
Between the years covered by Open Payments, Dr. Le received a total of $16,393 from 75 pharmaceutical and/or device companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Le is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in TX
$16,393 industry payments
Medicare Practice Summary
Medicare Utilization ↗85,813
Medicare services
Top 10% in TX for hematology & oncology
2,885
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,516 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
30,300 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
21,600 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 19,800 | $41 | $137 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,458 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,490 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 1,020 | $0 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,014 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
936 | $8 | $36 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
710 | $2 | $13 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
678 | $10 | $64 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
506 | $12 | $108 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
442 | $97 | $707 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
399 | $62 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $92 | $368 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
194 | $13 | $60 |
| Iron level test | 190 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
190 | $9 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
188 | $11 | $96 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
162 | $22 | $157 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
159 | $49 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
156 | $1 | $7 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 153 | $89 | $657 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
140 | $46 | $313 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
139 | $1,102 | $4,802 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 133 | $20 | $128 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
126 | $19 | $99 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
114 | $21 | $161 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
101 | $1 | $8 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
98 | $28 | $247 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
97 | $2 | $19 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
83 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
83 | $6 | $34 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
82 | $42 | $289 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
80 | $15 | $94 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
73 | $35 | $143 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
72 | $124 | $500 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
70 | $60 | $247 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
58 | $77 | $372 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $124 | $565 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
34 | $9 | $75 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $137 | $496 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
19 | $6 | $31 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
17 | $25 | $256 |
| New patient office visit, complex (60-74 min) | 15 | $168 | $709 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $40 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
92.9% medium
5.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,393
Total received (2018-2024)
Avg $2,342/year across 7 years
Top 23% in TX for hematology & oncology
75
Companies
477
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,891 (66.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,507 (27.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$995 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,499
2023
$5,219
2022
$2,188
2021
$2,423
2020
$354
2019
$455
2018
$257
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$2,344
Gilead Sciences, Inc.
$1,958
Baxter Healthcare
$1,395
Novartis Pharmaceuticals Corporation
$861
Janssen Scientific Affairs, LLC
$758
Merck Sharp & Dohme LLC
$563
Astellas Pharma US Inc
$560
Daiichi Sankyo Inc.
$556
AstraZeneca Pharmaceuticals LP
$454
Janssen Biotech, Inc.
$440
PFIZER INC.
$432
E.R. Squibb & Sons, L.L.C.
$395
Incyte Corporation
$395
Seagen Inc.
$302
Takeda Pharmaceuticals U.S.A., Inc.
$296
GENZYME CORPORATION
$193
Genentech USA, Inc.
$191
Puma Biotechnology, Inc.
$190
Epizyme, Inc.,
$186
Eisai Inc.
$185
SOBI, INC
$183
Kite Pharma, Inc.
$175
ABBVIE INC.
$165
PharmaEssentia USA Corporation
$156
Merck Sharp & Dohme Corporation
$154
Sirtex Medical Inc
$154
GlaxoSmithKline, LLC.
$150
Lilly USA, LLC
$139
Boehringer Ingelheim Pharmaceuticals, Inc.
$139
ARRAY BIOPHARMA INC
$135
Kyowa Kirin, Inc.
$131
Rigel Pharmaceuticals, Inc.
$112
Pharmacyclics LLC, An AbbVie Company
$111
Bayer Healthcare Pharmaceuticals Inc.
$107
Celgene Corporation
$89
Stemline Therapeutics Inc.
$80
Amgen Inc.
$80
Seattle Genetics, Inc.
$77
AVEO Pharmaceuticals, Inc.
$76
Adaptive Biotechnologies Corporation
$73
Apellis Pharmaceuticals, Inc.
$71
CTI BioPharma Corp.
$69
Mirati Therapeutics, Inc.
$64
Jazz Pharmaceuticals Inc.
$64
JAZZ PHARMACEUTICALS INC.
$63
Regeneron Healthcare Solutions, Inc.
$63
Myriad Genetic Laboratories, Inc.
$63
Karyopharm Therapeutics Inc.
$52
Aveo Pharmaceuticals, Inc.
$49
Sobi, Inc
$49
Ipsen Biopharmaceuticals, Inc
$46
Blueprint Medicines Corporation
$43
SERVIER PHARMACEUTICALS LLC
$42
PUMA BIOTECHNOLOGY, INC.
$41
ADC Therapeutics America, Inc.
$41
Exelixis Inc.
$39
Immunocore Limited
$34
Dendreon Pharmaceuticals LLC
$31
Acrotech Biopharma LLC
$27
Genmab U.S., Inc.
$27
GE HealthCare
$27
Pharmacyclics LLC, an AbbVie Company
$25
BeiGene USA, Inc.
$23
Masimo Corporation
$20
AbbVie Inc.
$20
PORTOLA PHARMACEUTICALS, INC.
$19
Acrotech Biopharma Inc.
$19
Foundation Medicine, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$18
MENARINI SILICON BIOSYSTEMS, INC.
$17
EISAI INC.
$16
SpringWorks Therapeutics, Inc.
$15
Cumberland Pharmaceuticals, Inc.
$14
TAIHO ONCOLOGY, INC.
$14
Janssen Pharmaceuticals, Inc
$7
Top 3 companies account for 34.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Asparlas · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · CREON · CYRAMZA · Cabometyx · Cellsearch · Cresemba · DARZALEX · DOPTELET · ELAHERE · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIVTENCITY · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Nplate · OGSIVEO · OJJAARA · OPDIVO · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Patient SafetyNet Console · Phesgo · Polivy · Pomalyst · Poteligeo · PreciseTumor · RYBREVANT · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SPRYCEL · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TAZVERIK · TECVAYLI · TEPMETKO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · VENCLEXTA · VERZENIO · VONJO · Vonjo · Voranigo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · YERVOY · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $19 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
129
Per 100K population
11.6
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Le is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Le experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Le performed 30,300 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Le receive payments from pharmaceutical companies?
Yes. Dr. Le received a total of $16,393 from 75 companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Le's costs compare to other hematology & oncology specialists in Plano?
Dr. Le's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Le) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Plano
Browse hematology & oncology specialists in Plano ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Baxter Healthcare Payments to Doctors
See all physicians who received payments from Baxter Healthcare.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology